シングルユース・バイオリアクター市場規模、シェア、動向、2031年までの世界予測

シングルユース・バイオリアクター（使い捨てバイオリアクター）市場は、2026年の推定54億3,000万米ドルから、2031年には95億8,000万米ドルに達し、予測期間（2026年～2031年）の年平均成長率（CAGR）は12.0%に達するとMarketsandMarketsでは予測しています。市場の成長は、主にバイオ医薬品およびバイオシミラーの生産拡大、ワクチン製造の増加、CDMO（医薬品受託開発製造業者）への委託の増加、そして柔軟性の高いバイオプロセス技術の採用拡大によって支えられています。モノクローナル抗体、組換えタンパク質、ウイルスベクター、細胞・遺伝子治療薬の製造におけるシングルユースシステムの利用拡大が、さらなる需要の増加を後押ししています。設備投資額の低さ、洗浄バリデーションの負担軽減、製品切り替えの迅速化、多品種生産施設への適合性といった利点が、市場の拡大を支えるものと見込まれます。

調査対象範囲

本調査レポートでは、シングルユース・バイオリアクター（使い捨てバイオリアクター）市場を以下の区分で分析しています：製品（シングルユース・バイオリアクター・システム、シングルユース・バッグ、シングルユース・アセンブリ、その他製品）、タイプ（撹拌槽型、ウェーブ型、固定床型、気泡塔型、その他）、細胞タイプ（哺乳類細胞、細菌細胞、酵母細胞、その他）、分子タイプ（モノクローナル抗体、ワクチン、細胞・遺伝子治療、治療用タンパク質・ペプチド）、プロセスモード（フェドバッチ、バッチ、灌流／連続）、用途（バイオ生産、プロセス開発、研究開発）、エンドユーザー（製薬・バイオテクノロジー企業、CRO・CMO、学術・研究機関）、および地域（北米、欧州、アジア太平洋、中南米、中東・アフリカ）。

本レポートでは、シングルユース・バイオリアクター市場の成長に影響を与える主要な要因（促進要因、課題、機会、阻害要因）について詳細な情報を提供します。また、主要な業界プレーヤーに関する包括的な分析を行い、事業概要、製品ポートフォリオ、主要戦略（提携、パートナーシップ、事業拡大、契約、買収、市場における最近の動向など）についての知見を提供します。

本レポートを購入するメリット

本レポートは、シングルユース・バイオリアクター（使い捨てバイオリアクター）市場の全体像を包括的に提示します。様々なセグメントにおける市場規模や将来の成長機会を評価することを目的としています。さらに、主要な市場プレーヤーに関する詳細な競合分析（企業概要、最近の動向、主要な市場戦略など）も掲載しています。

本レポートでは、以下の点に関する知見を提供します。

市場の成長に影響を与える要因の分析：主要な促進要因（CDMO、CMO、中小企業における柔軟なサブプラットフォームの採用拡大、従来のバイオリアクターと比較した運用上の利点、初期設備投資の低減、水・エネルギー消費の削減、バイオ医薬品およびバイオシミラーの製造需要の拡大）、阻害要因（溶出物・浸出物（E&L）への懸念、SUB導入に伴う規制・コンプライアンス要件、PFAS規制が製品開発に及ぼす影響）、機会（新興バイオ製造市場における未開拓の成長ポテンシャル、ハイブリッド型バイオ製造への移行）、および課題（標準化の欠如、廃棄物処理の負担と持続可能性への圧力、SUバッグの漏れや完全性喪失のリスク）。

• 製品開発・イノベーション：シングルユース・バイオリアクター（使い捨てバイオリアクター）市場における新製品に関する詳細な知見。
• 市場開拓：有望な市場に関する包括的な情報（様々な地域にわたる市場分析）。
• 市場の多角化：シングルユース・バイオリアクター市場における新製品、未開拓地域、最近の動向、投資に関する網羅的な情報。
• 競合状況の評価：主要企業（Sartorius AG（ドイツ）、Danaher Corporation（米国）、Thermo Fisher Scientific Inc.（米国）、Merck KGaA（ドイツ）、Avantor, Inc.（米国）、Repligen Corporation（米国）、Getinge AB（スウェーデン）、Eppendorf SE（ドイツ）、Parker Hannifin Corporation（米国）、Entegris（米国）、Saint-Gobain（フランス）、Corning Incorporated（米国）、Lonza（スイス）、TECNIC Process Equipment Manufacturing, S.L.）の市場シェア、成長戦略、製品ラインナップに関する詳細な評価。 (スペイン)、ZACROS株式会社 (日本)、Adolf Kühner AG (スイス)、OmniBRx Biotechnologies Pvt Ltd. (インド)、New Horizo​​n Biotechnology, Inc. (米国)、PBS Biotech, Inc. (米国)、bbi-biotech GmbH (ドイツ)、ABEC, Inc. (米国)、Esco Lifesciences Group (米国)、Distek, Inc. (米国)、サタケマルチミックス株式会社 (日本)、Cell Culture Company, LLC (米国)、MicroDigital Co., Ltd. (韓国)、BIONET (スペイン)、Meissner Filtration Products, Inc. (米国)、Solida Biotech GmbH (ドイツ)、G&G Technologies, Inc. (米国)、PharmNXT Biotech (インド)、およびTofflon Life Science Co., Ltd. (中国)。

Report Description

The single-use bioreactors market is projected to reach USD 9.58 billion by 2031 from an estimated USD 5.43 billion in 2026, at a CAGR of 12.0% during the forecast period of 2026 to 2031. Market growth is primarily supported by expanding biologics and biosimilar production, rising vaccine manufacturing, increasing outsourcing to CDMOs, and greater adoption of flexible bioprocessing technologies. The growing use of single-use systems in monoclonal antibody, recombinant protein, viral vector, and cell & gene therapy manufacturing is further accelerating demand. Their lower capital requirements, reduced cleaning validation, faster product changeovers, and suitability for multiproduct facilities are expected to support market expansion.

By application, the bioproduction segment accounted for the largest share of the market in 2025.

In 2025, the bioproduction segment accounted for the largest share of the global single-use bioreactors market. These systems are extensively used for the commercial and clinical production of monoclonal antibodies, vaccines, recombinant proteins, biosimilars, viral vectors, and other biologics. The segment’s leading position is supported by increasing demand for biologics, expansion of global manufacturing capacity, and growing adoption of scalable single-use platforms across pharmaceutical and biotechnology companies and CDMOs. Their ability to reduce contamination risks, shorten turnaround times, and support batch, fed-batch, and perfusion processes further strengthens their use in bioproduction applications.

The monoclonal antibodies segment accounted for a major share of the single-use bioreactors market in 2025.

The single-use bioreactors market is categorized by molecule type into monoclonal antibodies, vaccines, cell & gene therapy, and therapeutic proteins & peptides. The monoclonal antibodies segment accounted for the largest market share in 2025, supported by the substantial number of approved products, extensive development pipelines, and continued expansion of commercial manufacturing capacity. Monoclonal antibody production requires scalable and tightly controlled mammalian cell culture processes, creating sustained demand for stirred-tank single-use bioreactors, bags, assemblies, sensors, and fluid-management components. Their suitability for batch, fed-batch, and intensified processing further supports adoption across pharmaceutical and biotechnology companies and CDMOs.

The Asia Pacific region is expected to experience the highest CAGR in the single-use bioreactors market from 2026 to 2031.

The single-use bioreactors market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biologics and biosimilar production, increasing vaccine manufacturing, rising CDMO capacity, and greater investment in domestic biopharmaceutical infrastructure. China, India, Japan, South Korea, and Australia are strengthening their upstream processing capabilities through new facilities, capacity additions, and wider adoption of modular and flexible production technologies. Government support for local manufacturing and the growth of cell & gene therapy activity are further accelerating regional demand.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (80%) and Demand Side (20%)
• By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
• By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kühner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China) are some of the key companies offering single-use bioreactors solutions.

Research Coverage

This research report categorizes the single-use bioreactors market by product (single-use bioreactor systems, single-use bags, single-use assemblies, and other products), type (stirred-tank single-use bioreactors, wave-induced single-use bioreactors, fixed-bed single-use bioreactors, bubble-column single-use bioreactors, and other single-use bioreactors), cell type (mammalian cells, bacterial cells, yeast cells, and other cells), molecule type (monoclonal antibodies, vaccines, cell & gene therapy, and therapeutic proteins & peptides), process mode (fed-batch, batch, and perfusion/continuous), application (bioproduction, process development, and research & development), end user (pharmaceutical and biotechnology companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the single-use bioreactors market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the single-use bioreactors market.

Key Benefits of Buying the Report

This report offers a comprehensive overview of the single-use bioreactors market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies

The report provides insights into the following pointers:

Analysis of key drivers (rising adoption of flexible sub platforms among CDMOs, CMOs, and SMEs, operational advantages over conventional bioreactors, reduced upfront capital investment, reduced water and energy consumption, and expansion of biologics and biosimilar manufacturing demand), restraints (concerns related to extractables and leachables, regulatory and compliance requirements for SUB implementation, and impact of PFAS restrictions on product development), opportunities (untapped growth potential in emerging biomanufacturing economies and shift toward hybrid biomanufacturing), and challenges (lack of standardization, waste disposal burden and sustainability pressure, and risk of SU bag leakage and integrity failure) influencing the growth of the market.

• Product Development/Innovation: Detailed insights on newly launched products of the single-use bioreactors market.
• Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use bioreactors market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kühner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China).

Table of Contents

1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 STUDY SCOPE 42
1.3.1 MARKET SEGMENTATION & REGIONS COVERED 43
1.3.2 INCLUSIONS & EXCLUSIONS 44
1.3.3 YEARS CONSIDERED 45
1.3.4 CURRENCY CONSIDERED 45
1.4 STAKEHOLDERS 45
1.5 SUMMARY OF CHANGES 46
2 EXECUTIVE SUMMARY 47
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 47
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 49
2.3 DISRUPTIVE TRENDS IN SINGLE-USE BIOREACTORS MARKET 50
2.4 HIGH-GROWTH SEGMENTS 51
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 52
3 PREMIUM INSIGHTS 53
3.1 GLOBAL SINGLE-USE BIOREACTORS MARKET SNAPSHOT 53
3.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT AND COUNTRY, 2025 54
3.3 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
3.4 SINGLE-USE BIOREACTORS MARKET SHARE, BY END USER, 2026 VS. 2031 (%) 56
4 MARKET OVERVIEW 57
4.1 INTRODUCTION 57
4.2 MARKET DYNAMICS 57
4.2.1 DRIVERS 58
4.2.1.1 Rising adoption of flexible SUB platforms among CDMOs,
CMOs, and SMEs 58
4.2.1.2 Operational advantages over conventional bioreactors 59
4.2.1.3 Reduced upfront capital investment 60
4.2.1.4 Reduced water and energy consumption 61
4.2.1.5 Expansion of biologics and biosimilar manufacturing demand 62
4.2.2 RESTRAINTS 64
4.2.2.1 Concerns related to extractables and leachables 64
4.2.2.2 Regulatory and compliance requirements for SUB implementation 64
4.2.2.3 Impact of PFAS restrictions on product development 65
4.2.3 OPPORTUNITIES 66
4.2.3.1 Untapped growth potential in emerging biomanufacturing economies 66
4.2.3.2 Shift towards hybrid biomanufacturing 67
4.2.4 CHALLENGES 67
4.2.4.1 Lack of standardization 67
4.2.4.2 Waste disposal burden and sustainability pressure 68
4.2.4.3 Risk of SU bag leakage and integrity failure 69
4.3 UNMET NEEDS & WHITE SPACES 70
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 70
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 71
5 INDUSTRY TRENDS 72
5.1 PORTER’S FIVE FORCES ANALYSIS 72
5.1.1 BARGAINING POWER OF SUPPLIERS 73
5.1.2 BARGAINING POWER OF BUYERS 73
5.1.3 THREAT OF NEW ENTRANTS 73
5.1.4 THREAT OF SUBSTITUTES 73
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.2 MACROECONOMIC OUTLOOK 74
5.2.1 INTRODUCTION 74
5.2.2 GDP TRENDS & FORECAST 74
5.2.3 TRENDS IN GLOBAL SINGLE-USE BIOREACTORS INDUSTRY 75
5.3 VALUE CHAIN ANALYSIS 76
5.4 ECOSYSTEM ANALYSIS 77
5.5 PRICING ANALYSIS 80
5.5.1 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY KEY PLAYER, 2023–2025 81
5.5.2 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2023–2025 83
5.6 TRADE ANALYSIS 85
5.6.1 IMPORT SCENARIO (HS CODE 841989) 85
5.6.2 EXPORT SCENARIO (HS CODE 841989) 87
5.7 KEY CONFERENCES & EVENTS, 2026–2027 89
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89
5.9 INVESTMENT & FUNDING SCENARIO 91
5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 91
5.10 IMPACT OF 2025 US TARIFFS ON SINGLE-USE BIOREACTORS MARKET 92
5.10.1 INTRODUCTION 92
5.10.2 KEY TARIFF RATES 92
5.10.3 PRICE IMPACT ANALYSIS 93
5.10.4 IMPACT ON COUNTRIES/REGIONS 94
5.10.4.1 US 94
5.10.4.2 Europe 94
5.10.4.3 Asia Pacific 94
5.10.5 IMPACT ON END-USE INDUSTRIES 95
5.10.5.1 Pharmaceutical & biotechnology companies 95
5.10.5.2 CROs & CMOs 96
5.10.5.3 Academic & research institutes 96
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT,
PATENTS, AND INNOVATIONS 97
6.1 TECHNOLOGY ANALYSIS 97
6.1.1 KEY EMERGING TECHNOLOGIES 97
6.1.1.1 Fermentation 97
6.1.1.2 Continuous bioprocessing 97
6.1.1.3 3D cell culture 98
6.1.2 COMPLEMENTARY TECHNOLOGIES 98
6.1.2.1 Automation & control 98
6.1.2.2 Data analytics & machine learning 98
6.1.3 ADJACENT TECHNOLOGIES 99
6.1.3.1 Filtration 99
6.1.3.2 Cell separation 99
6.2 TECHNOLOGY/PRODUCT ROADMAP 99
6.3 PATENT ANALYSIS 100
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTOR PATENTS 100
6.4 FUTURE APPLICATIONS 103
6.5 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET 104
6.5.1 BEST PRACTICES IN SINGLE-USE BIOREACTORS WORKFLOW 105
6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET 105
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 106
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS MARKET 106
7 SUSTAINABILITY & REGULATORY LANDSCAPE 107
7.1 REGIONAL REGULATIONS & COMPLIANCE 107
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 107
7.1.2 REGULATORY FRAMEWORK 110
7.1.2.1 North America 110
7.1.2.2 Europe 111
7.1.2.3 Asia Pacific 111
7.1.2.4 Rest of the World 111
7.1.3 INDUSTRY STANDARDS 111
7.2 SUSTAINABILITY INITIATIVES 112
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 113
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 113
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 115
8.1 DECISION-MAKING PROCESS 115
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 115
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 115
8.2.2 KEY BUYING CRITERIA, BY END USER 117
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 119
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 119
8.5 MARKET PROFITABILITY 119
9 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT 120
9.1 INTRODUCTION 121
9.2 SINGLE-USE BIOREACTOR SYSTEMS 121
9.2.1 ≤10 L BIOREACTORS 126
9.2.1.1 High-throughput process development and scale-down studies to support market growth 126
9.2.2 11–100 L BIOREACTORS 129
9.2.2.1 Increasing pilot-scale and clinical manufacturing to support market growth 129
9.2.3 101–500 L BIOREACTORS 133
9.2.3.1 Flexible scale-up from clinical to early commercial production to propel market growth 133
9.2.4 501–1,500 L BIOREACTORS 136
9.2.4.1 Expanding late-stage and commercial biologics capacity to support market growth 136
9.2.5 >1,500 L BIOREACTORS 140
9.2.5.1 Large-scale single-use commercialization to strengthen market position 140
9.3 SINGLE-USE BAGS 143
9.3.1 2D SINGLE-USE BAGS 146
9.3.1.1 Low-volume flexibility and expanding cell therapy applications to support market growth 146
9.3.2 3D SINGLE-USE BAGS 150
9.3.2.1 Large-volume biologics production to support market growth 150
9.4 SINGLE-USE ASSEMBLIES 153
9.4.1 INCREASING ADOPTION OF CLOSED FLUID PATHS TO SUPPORT MARKET GROWTH 153
9.5 OTHER PRODUCTS 156
10 SINGLE-USE BIOREACTORS MARKET, BY TYPE 160
10.1 INTRODUCTION 161
10.2 STIRRED-TANK SINGLE-USE BIOREACTORS 161
10.2.1 BROAD SCALABILITY AND COMPATIBILITY WITH INTENSIFIED CELL CULTURE TO SUPPORT MARKET GROWTH 161
10.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 165
10.3.1 INCREASING ADOPTION IN CELL THERAPY AND SEED-TRAIN APPLICATIONS TO SUPPORT MARKET GROWTH 165
10.4 FIXED-BED SINGLE-USE BIOREACTORS 169
10.4.1 HIGH-DENSITY ADHERENT CELL AND VIRAL VECTOR PRODUCTION TO DRIVE FASTEST MARKET GROWTH 169
10.5 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 173
10.5.1 IMPELLER-FREE MIXING AND EXPANDING MICROBIAL APPLICATIONS TO SUPPORT MARKET GROWTH 173
10.6 OTHER SINGLE-USE BIOREACTORS 176
11 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE 180
11.1 INTRODUCTION 181
11.2 MONOCLONAL ANTIBODIES 181
11.2.1 EXPANDING THERAPEUTIC PIPELINES AND BIOSIMILAR PRODUCTION TO SUPPORT SEGMENT DOMINANCE 181
11.3 VACCINES 185
11.3.1 EXPANDING VACCINE PIPELINES AND FLEXIBLE MANUFACTURING REQUIREMENTS TO SUPPORT MARKET GROWTH 185
11.4 CELL & GENE THERAPY 188
11.4.1 EXPANDING ADVANCED THERAPY PIPELINES AND MANUFACTURING INVESTMENTS TO SUPPORT MARKET GROWTH 188
11.5 THERAPEUTIC PROTEINS & PEPTIDES 192
11.5.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS AND PEPTIDE THERAPEUTICS TO SUPPORT MARKET GROWTH 192
12 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE 196
12.1 INTRODUCTION 197
12.2 MAMMALIAN CELLS 197
12.2.1 HIGH DEMAND FOR COMPLEX BIOLOGICS TO SUPPORT SEGMENT DOMINANCE 197
12.3 BACTERIAL CELLS 201
12.3.1 EXPANDING PLASMID DNA AND RECOMBINANT PROTEIN PRODUCTION TO SUPPORT MARKET GROWTH 201
12.4 YEAST CELLS 204
12.4.1 INCREASING USE IN RECOMBINANT PROTEIN AND VACCINE PRODUCTION TO SUPPORT MARKET GROWTH 204
12.5 OTHER CELLS 208
13 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION 212
13.1 INTRODUCTION 213
13.2 BIOPRODUCTION 213
13.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP 213
13.3 PROCESS DEVELOPMENT 217
13.3.1 ACCELERATED PROCESS OPTIMIZATION TO DRIVE GROWTH OF PROCESS DEVELOPMENT APPLICATIONS 217
13.4 RESEARCH & DEVELOPMENT 220
13.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVE FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING 220
14 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE 224
14.1 INTRODUCTION 225
14.2 FED-BATCH PROCESS MODE 225
14.2.1 COMMERCIAL BIOLOGICS MANUFACTURING TO CONTINUE TO POSITION FED-BATCH AS LARGEST PROCESS SEGMENT 225
14.3 BATCH PROCESS MODE 229
14.3.1 PROCESS DEVELOPMENT AND SMALL-SCALE BIOLOGICS PRODUCTION TO SUSTAIN DEMAND FOR BATCH PROCESSING 229
14.4 PERFUSION/CONTINUOUS PROCESS MODE 232
14.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVES FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING 232
15 SINGLE-USE BIOREACTORS MARKET, BY END USER 236
15.1 INTRODUCTION 237
15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 237
15.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP 237
15.3 CROS & CDMOS 241
15.3.1 BIOLOGICS OUTSOURCING TO DRIVE GROWTH AMONG CROS AND CMOS 241
15.4 ACADEMIC & RESEARCH INSTITUTES 244
15.4.1 EXPANDING LIFE SCIENCE RESEARCH TO CONTINUE TO SUPPORT DEMAND FROM ACADEMIC & RESEARCH INSTITUTES 244
16 SINGLE-USE BIOREACTORS MARKET, BY REGION 248
16.1 INTRODUCTION 249
16.2 NORTH AMERICA 249
16.2.1 US 254
16.2.1.1 US to dominate North American market during study period 254
16.2.2 CANADA 258
16.2.2.1 Public bio­manufacturing investment and advanced-therapy capacity expansion to support market growth 258
16.3 EUROPE 261
16.3.1 GERMANY 265
16.3.1.1 Strong bioprocessing ecosystem and expanding therapeutic pipelines to support market growth 265
16.3.2 UK 269
16.3.2.1 Public funding and advanced-therapy manufacturing to support market growth 269
16.3.3 FRANCE 272
16.3.3.1 Strong bioprocessing supply base and biopharmaceutical investments to support market growth 272
16.3.4 ITALY 276
16.3.4.1 Strong pharmaceutical manufacturing and advanced-therapy capabilities to support market growth 276
16.3.5 SPAIN 280
16.3.5.1 Expanding biotechnology R&D and CDMO capacity to support market growth 280
16.3.6 REST OF EUROPE 283
16.4 ASIA PACIFIC 287
16.4.1 CHINA 293
16.4.1.1 Large biologics pipeline and commercial-scale single-use capacity to drive market growth 293
16.4.2 SOUTH KOREA 297
16.4.2.1 Large-scale CDMO capacity and export-oriented biopharmaceutical industry to support market growth 297
16.4.3 JAPAN 301
16.4.3.1 Biologics pipeline expansion and regenerative medicine commercialization to support market growth 301
16.4.4 INDIA 305
16.4.4.1 Export-oriented biopharmaceutical industry and policy support to drive market growth 305
16.4.5 AUSTRALIA 309
16.4.5.1 Clinical research funding and advanced-therapy manufacturing to support market growth 309
16.4.6 REST OF ASIA PACIFIC 312
16.5 LATIN AMERICA 316
16.5.1 BRAZIL 320
16.5.1.1 Public bioproduction investment and expanding vaccine capabilities to support market growth 320
16.5.2 MEXICO 324
16.5.2.1 Domestic biopharmaceutical capacity expansion to support market growth 324
16.5.3 REST OF LATIN AMERICA 327
16.6 MIDDLE EAST 331
16.6.1 GCC COUNTRIES 335
16.6.1.1 Saudi Arabia 338
16.6.1.1.1 National biotechnology strategy and commercial biopharma capacity to propel market growth 338
16.6.1.2 UAE 342
16.6.1.2.1 Vaccine manufacturing and regulatory ecosystem development to support market growth 342
16.6.1.3 Rest of GCC countries 345
16.6.2 REST OF MIDDLE EAST 348
16.7 AFRICA 352
16.7.1 VACCINE MANUFACTURING LOCALIZATION AND TECHNOLOGY TRANSFER TO SUPPORT MARKET GROWTH 352
17 COMPETITIVE LANDSCAPE 356
17.1 OVERVIEW 356
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 356
17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE BIOREACTORS MARKET 356
17.3 REVENUE ANALYSIS, 2021–2025 358
17.4 MARKET SHARE ANALYSIS, 2025 359
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 361
17.5.1 STARS 361
17.5.2 EMERGING LEADERS 361
17.5.3 PERVASIVE PLAYERS 362
17.5.4 PARTICIPANTS 362
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 363
17.5.5.1 Company footprint 363
17.5.5.2 Region footprint 364
17.5.5.3 Product footprint 365
17.5.5.4 Type footprint 366
17.5.5.5 Application footprint 367
17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 368
17.6.1 PROGRESSIVE COMPANIES 368
17.6.2 RESPONSIVE COMPANIES 368
17.6.3 DYNAMIC COMPANIES 368
17.6.4 STARTING BLOCKS 368
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 370
17.6.5.1 Detailed list of key startups/SMEs 370
17.6.5.2 Competitive benchmarking of key startups/SMEs 372
17.7 COMPANY VALUATION & FINANCIAL METRICS 373
17.7.1 FINANCIAL METRICS 373
17.7.2 COMPANY VALUATION 373
17.8 BRAND/PRODUCT COMPARISON 374
17.9 COMPETITIVE SCENARIO 375
17.9.1 PRODUCT LAUNCHES 375
17.9.2 DEALS 376
17.9.3 EXPANSIONS 377
18 COMPANY PROFILES 378
18.1 KEY PLAYERS 378
18.1.1 SARTORIUS AG 378
18.1.1.1 Business overview 378
18.1.1.2 Products offered 379
18.1.1.3 Recent developments 381
18.1.1.3.1 Product launches 381
18.1.1.3.2 Deals 381
18.1.1.3.3 Expansions 382
18.1.1.4 MnM view 383
18.1.1.4.1 Key strengths 383
18.1.1.4.2 Strategic choices 383
18.1.1.4.3 Weaknesses & competitive threats 383
18.1.2 DANAHER CORPORATION 384
18.1.2.1 Business overview 384
18.1.2.2 Products offered 386
18.1.2.3 Recent developments 388
18.1.2.3.1 Product launches 388
18.1.2.3.2 Deals 388
18.1.2.3.3 Expansions 389
18.1.2.4 MnM view 390
18.1.2.4.1 Right to win 390
18.1.2.4.2 Strategic choices 390
18.1.2.4.3 Weaknesses & competitive threats 390
18.1.3 THERMO FISHER SCIENTIFIC INC. 391
18.1.3.1 Business overview 391
18.1.3.2 Products offered 393
18.1.3.3 Recent developments 394
18.1.3.3.1 Product launches 394
18.1.3.3.2 Deals 395
18.1.3.3.3 Expansions 396
18.1.3.4 MnM view 396
18.1.3.4.1 Right to win 396
18.1.3.4.2 Strategic choices 397
18.1.3.4.3 Weaknesses & competitive threats 397
18.1.4 MERCK KGAA 398
18.1.4.1 Business overview 398
18.1.4.2 Products offered 400
18.1.4.3 Recent developments 401
18.1.4.3.1 Product launches 401
18.1.4.3.2 Deals 401
18.1.4.3.3 Expansions 402
18.1.4.4 MnM view 403
18.1.4.4.1 Right to win 403
18.1.4.4.2 Strategic choices 403
18.1.4.4.3 Weaknesses & competitive threats 403
18.1.5 AVANTOR, INC. 404
18.1.5.1 Business overview 404
18.1.5.2 Products offered 406
18.1.5.3 Recent developments 407
18.1.5.3.1 Deals 407
18.1.5.3.2 Expansions 407
18.1.6 REPLIGEN CORPORATION 408
18.1.6.1 Business overview 408
18.1.6.2 Products offered 410
18.1.6.3 Recent developments 411
18.1.6.3.1 Deals 411
18.1.6.3.2 Expansions 411
18.1.7 GETINGE AB 412
18.1.7.1 Business overview 412
18.1.7.2 Products offered 414
18.1.7.3 Recent developments 415
18.1.7.3.1 Product launches 415
18.1.7.3.2 Deals 415
18.1.7.3.3 Expansions 416
18.1.8 EPPENDORF SE 417
18.1.8.1 Business overview 417
18.1.8.2 Products offered 418
18.1.8.3 Recent developments 419
18.1.8.3.1 Deals 419
18.1.8.3.2 Expansions 419
18.1.9 PARKER HANNIFIN CORPORATION 420
18.1.9.1 Business overview 420
18.1.9.2 Products offered 422
18.1.10 ENTEGRIS 423
18.1.10.1 Business overview 423
18.1.10.2 Products offered 425
18.1.11 SAINT-GOBAIN 426
18.1.11.1 Business overview 426
18.1.11.2 Products offered 427
18.1.11.3 Recent developments 428
18.1.11.3.1 Product launches 428
18.1.11.3.2 Expansions 428
18.1.12 CORNING INCORPORATED 429
18.1.12.1 Business overview 429
18.1.12.2 Products offered 430
18.1.13 LONZA 431
18.1.13.1 Business overview 431
18.1.13.2 Products offered 432
18.1.13.3 Recent developments 433
18.1.13.3.1 Deals 433
18.1.14 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L. 434
18.1.14.1 Business overview 434
18.1.14.2 Products offered 434
18.1.14.3 Recent developments 435
18.1.14.3.1 Product launches 435
18.1.14.3.2 Expansions 435
18.1.15 ZACROS CORPORATION 436
18.1.15.1 Business overview 436
18.1.15.2 Products offered 437
18.2 OTHER PLAYERS 438
18.2.1 ADOLF KÜHNER AG 438
18.2.2 OMNIBRX BIOTECHNOLOGIES PVT LTD. 439
18.2.3 NEW HORIZON BIOTECHNOLOGY, INC. 440
18.2.4 PBS BIOTECH, INC. 441
18.2.5 BBI-BIOTECH GMBH 442
18.2.6 ABEC, INC. 443
18.2.7 ESCO LIFESCIENCES GROUP 444
18.2.8 DISTEK, INC. 445
18.2.9 SATAKE MULTIMIX CORPORATION 446
18.2.10 CELL CULTURE COMPANY, LLC 447
18.2.11 MICRODIGITAL CO., LTD. 448
18.2.12 BIONET 449
18.2.13 MEISSNER FILTRATION PRODUCTS, INC. 450
18.2.14 SOLIDA BIOTECH GMBH 451
18.2.15 G&G TECHNOLOGIES, INC. 451
18.2.16 PHARMNXT BIOTECH 452
18.2.17 TOFFLON LIFE SCIENCE CO., LTD. 452
18.2.18 SHANGHAI LEPURE BIOTECH CO., LTD. 453
19 RESEARCH METHODOLOGY 454
19.1 RESEARCH DATA 454
19.1.1 SECONDARY DATA 455
19.1.1.1 Key secondary sources 455
19.1.1.2 Key data from secondary research 455
19.1.2 PRIMARY DATA 456
19.1.2.1 Key primary participants 456
19.1.2.2 Breakdown of primary interviews 456
19.1.2.3 Key data from primary sources 456
19.2 MARKET SIZE ESTIMATION 457
19.2.1 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025 457
19.2.1.1 Approach 1: Company revenue analysis-based estimation
(bottom-up) 457
19.2.1.2 Approach 2: Primary research 459
19.2.1.2.1 Key industry insights 459
19.2.1.3 Approach 3: MnM repository analysis 459
19.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025 460
19.3 MARKET GROWTH RATE PROJECTIONS 462
19.4 DATA TRIANGULATION 464
19.5 RESEARCH ASSUMPTIONS 465
19.6 RESEARCH LIMITATIONS & RISK ASSESSMENT 466
20 APPENDIX 467
20.1 DISCUSSION GUIDE 467
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 472
20.3 CUSTOMIZATION OPTIONS 474
20.4 RELATED REPORTS 475
20.5 AUTHOR DETAILS 476

LIST OF TABLES

TABLE 1 SINGLE-USE BIOREACTORS MARKET: INCLUSIONS AND EXCLUSIONS 44
TABLE 2 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 58
TABLE 3 COMPARISON OF SINGLE-USE AND MULTI-USE BIOREACTORS 59
TABLE 4 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS
(COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE) 62
TABLE 5 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS 68
TABLE 6 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS 69
TABLE 7 SINGLE-USE BIOREACTORS MARKET: IMPACT OF PORTER’S FIVE FORCES 73
TABLE 8 SINGLE-USE BIOREACTORS MARKET: ROLE IN ECOSYSTEM 79
TABLE 9 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS,
BY KEY PLAYER, 2023–2025 (USD) 81
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS,
BY REGION, 2023–2025 (USD) 83
TABLE 11 IMPORT DATA FOR HS CODE 841989, 2021–2025 (USD THOUSAND) 85
TABLE 12 IMPORT DATA FOR HS CODE 841989, 2021–2025 (UNITS) 86
TABLE 13 EXPORT DATA FOR HS CODE 841989, 2021–2025 (USD THOUSAND) 87
TABLE 14 EXPORT DATA FOR HS CODE 841989, 2021–2025 (TONS) 88
TABLE 15 SINGLE-USE BIOREACTORS MARKET: KEY CONFERENCES & EVENTS, 2026–2027 89
TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 92
TABLE 17 SINGLE-USE BIOREACTORS MARKET: INDICATIVE LIST OF PATENTS, 2026 101
TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET 105
TABLE 19 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS 106
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 107
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 108
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 109
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
TABLE 24 COMPARATIVE ENVIRONMENTAL PROFILE OF SINGLE-USE AND STAINLESS STEEL BIOPROCESSING PLATFORMS ACROSS KEY SUSTAINABILITY INDICATORS 112
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 116
TABLE 26 KEY BUYING CRITERIA, BY END USER 117
TABLE 27 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 121
TABLE 28 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS 122
TABLE 29 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2024–2031 (USD MILLION) 122
TABLE 30 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 123
TABLE 31 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 32 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 33 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 34 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 35 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 125
TABLE 36 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 37 ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 126
TABLE 38 NORTH AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 39 EUROPE: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 40 ASIA PACIFIC: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 41 LATIN AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 42 MIDDLE EAST: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 128
TABLE 43 GCC COUNTRIES: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 44 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 130
TABLE 45 NORTH AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 46 EUROPE: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 47 ASIA PACIFIC: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 48 LATIN AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 49 MIDDLE EAST: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 50 GCC COUNTRIES: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 51 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 133
TABLE 52 NORTH AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 53 EUROPE: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 54 ASIA PACIFIC: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 55 LATIN AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 56 MIDDLE EAST: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 135
TABLE 57 GCC COUNTRIES: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 58 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 137
TABLE 59 NORTH AMERICA: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 60 EUROPE: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 61 ASIA PACIFIC: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 62 LATIN AMERICA: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 63 MIDDLE EAST: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 139
TABLE 64 GCC COUNTRIES: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 65 >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 140
TABLE 66 NORTH AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 67 EUROPE: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 68 ASIA PACIFIC: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 69 LATIN AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 70 MIDDLE EAST: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 142
TABLE 71 GCC COUNTRIES: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 72 SINGLE-USE BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 73 SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 144
TABLE 74 NORTH AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 75 EUROPE: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 76 ASIA PACIFIC: SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 77 LATIN AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 78 MIDDLE EAST: SINGLE-USE BAGS MARKET, BY REGION,
2024–2031 (USD MILLION) 146
TABLE 79 GCC COUNTRIES: SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 80 2D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 81 NORTH AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 82 EUROPE: 2D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 83 ASIA PACIFIC: 2D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 84 LATIN AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 85 MIDDLE EAST: 2D SINGLE-USE BAGS MARKET, BY REGION,
2024–2031 (USD MILLION) 149
TABLE 86 GCC COUNTRIES: 2D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 87 3D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 150
TABLE 88 NORTH AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 151
TABLE 89 EUROPE: 3D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 151
TABLE 90 ASIA PACIFIC: 3D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 151
TABLE 91 LATIN AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 152
TABLE 92 MIDDLE EAST: 3D SINGLE-USE BAGS MARKET, BY REGION,
2024–2031 (USD MILLION) 152
TABLE 93 GCC COUNTRIES: 3D SINGLE-USE BAGS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 152
TABLE 94 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2024–2031 (USD MILLION) 153
TABLE 95 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 96 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 97 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 98 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 99 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY REGION,
2024–2031 (USD MILLION) 155
TABLE 100 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 101 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION,
2024–2031 (USD MILLION) 156
TABLE 102 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 103 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 104 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 105 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 106 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY REGION, 2024–2031 (USD MILLION) 159
TABLE 107 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 108 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161
TABLE 109 EXAMPLES OF STIRRED-TANK SINGLE-USE BIOREACTOR SYSTEMS 162
TABLE 110 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 162
TABLE 111 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 112 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 113 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 114 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 115 MIDDLE EAST: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 164
TABLE 116 GCC COUNTRIES: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 117 EXAMPLES OF WAVE-INDUCED SINGLE-USE BIOREACTOR SYSTEMS 166
TABLE 118 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 166
TABLE 119 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 120 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 121 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 122 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 123 MIDDLE EAST: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 168
TABLE 124 GCC COUNTRIES: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 125 EXAMPLES OF FIXED-BED SINGLE-USE BIOREACTOR SYSTEMS 169
TABLE 126 FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY REGION,
2024–2031 (USD MILLION) 170
TABLE 127 NORTH AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 128 EUROPE: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 129 ASIA PACIFIC: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 130 LATIN AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 131 MIDDLE EAST: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 172
TABLE 132 GCC COUNTRIES: FIXED-BED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 133 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 173
TABLE 134 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 135 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 136 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 137 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 138 MIDDLE EAST: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 175
TABLE 139 GCC COUNTRIES: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 140 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION,
2024–2031 (USD MILLION) 177
TABLE 141 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 142 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 143 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 144 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 145 MIDDLE EAST: OTHER SINGLE-USE BIOREACTORS MARKET,
BY REGION, 2024–2031 (USD MILLION) 179
TABLE 146 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 147 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 181
TABLE 148 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES,
BY REGION, 2024–2031 (USD MILLION) 182
TABLE 149 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 150 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES,
BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 151 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 152 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 153 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 154 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 155 SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY REGION, 2024–2031 (USD MILLION) 185
TABLE 156 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 157 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 158 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 159 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 160 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY REGION, 2024–2031 (USD MILLION) 187
TABLE 161 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 162 SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY,
BY REGION, 2024–2031 (USD MILLION) 189
TABLE 163 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 164 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 165 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 166 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 167 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2024–2031 (USD MILLION) 191
TABLE 168 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 169 SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES,
BY REGION, 2024–2031 (USD MILLION) 192
TABLE 170 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 171 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 172 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 194
TABLE 173 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 194
TABLE 174 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 175 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 176 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 197
TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY REGION, 2024–2031 (USD MILLION) 198
TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 179 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 180 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 181 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 182 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY REGION, 2024–2031 (USD MILLION) 200
TABLE 183 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 184 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY REGION, 2024–2031 (USD MILLION) 201
TABLE 185 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 202
TABLE 186 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 202
TABLE 187 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 188 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 189 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY REGION, 2024–2031 (USD MILLION) 203
TABLE 190 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 191 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY REGION, 2024–2031 (USD MILLION) 205
TABLE 192 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 205
TABLE 193 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 206
TABLE 194 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 206
TABLE 195 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 207
TABLE 196 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY REGION, 2024–2031 (USD MILLION) 207
TABLE 197 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 207
TABLE 198 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY REGION, 2024–2031 (USD MILLION) 208
TABLE 199 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 200 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 201 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 202 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 203 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY REGION, 2024–2031 (USD MILLION) 211
TABLE 204 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 205 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 213
TABLE 206 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY REGION, 2024–2031 (USD MILLION) 214
TABLE 207 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 214
TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 209 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 210 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 211 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY REGION, 2024–2031 (USD MILLION) 216
TABLE 212 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 213 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2024–2031 (USD MILLION) 217
TABLE 214 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 215 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 216 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 217 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 218 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 219
TABLE 219 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 220
TABLE 220 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 221
TABLE 221 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 221
TABLE 222 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 223 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 224 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 225 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 223
TABLE 226 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 227 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 225
TABLE 228 SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE,
BY REGION, 2024–2031 (USD MILLION) 226
TABLE 229 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 226
TABLE 230 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 231 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 232 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 233 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 228
TABLE 234 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 235 SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE,
BY REGION, 2024–2031 (USD MILLION) 229
TABLE 236 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 237 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE,
BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 238 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 231
TABLE 239 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 231
TABLE 240 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 231
TABLE 241 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 232
TABLE 242 SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 233
TABLE 243 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY,
2024–2031 (USD MILLION) 233
TABLE 244 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 245 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 246 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 235
TABLE 247 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 235
TABLE 248 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 235
TABLE 249 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 237
TABLE 250 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 238
TABLE 251 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 252 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 239
TABLE 253 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 239
TABLE 254 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 255 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 240
TABLE 256 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 257 SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY REGION,
2024–2031 (USD MILLION) 241
TABLE 258 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 242
TABLE 259 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 242
TABLE 260 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 261 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 262 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY REGION, 2024–2031 (USD MILLION) 243
TABLE 263 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 264 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2024–2031 (USD MILLION) 245
TABLE 265 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 266 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 246
TABLE 267 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 246
TABLE 268 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 247
TABLE 269 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 247
TABLE 270 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 247
TABLE 271 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 249
TABLE 272 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 250
TABLE 273 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 251
TABLE 274 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 275 NORTH AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 276 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 277 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 252
TABLE 278 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 252
TABLE 279 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 253
TABLE 280 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 253
TABLE 281 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 253
TABLE 282 NATIONAL INSTITUTES OF HEALTH FUNDING, FY2024–FY2026 254
TABLE 283 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 255
TABLE 284 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 285 US: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 286 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 287 US: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 256
TABLE 288 US: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 256
TABLE 289 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 257
TABLE 290 US: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 257
TABLE 291 US: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 257
TABLE 292 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 258
TABLE 293 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 294 CANADA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 295 CANADA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 296 CANADA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 260
TABLE 297 CANADA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 260
TABLE 298 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 260
TABLE 299 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 261
TABLE 300 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 261
TABLE 301 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 262
TABLE 302 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 262
TABLE 303 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 304 EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 305 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 306 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 263
TABLE 307 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 264
TABLE 308 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 264
TABLE 309 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 264
TABLE 310 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 265
TABLE 311 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 266
TABLE 312 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 313 GERMANY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 314 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 315 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 267
TABLE 316 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 267
TABLE 317 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 268
TABLE 318 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 268
TABLE 319 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 268
TABLE 320 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 269
TABLE 321 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 322 UK: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 323 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 324 UK: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 271
TABLE 325 UK: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 271
TABLE 326 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 271
TABLE 327 UK: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 272
TABLE 328 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 272
TABLE 329 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 273
TABLE 330 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 331 FRANCE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 332 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 333 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 274
TABLE 334 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 275
TABLE 335 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 275
TABLE 336 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 275
TABLE 337 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 276
TABLE 338 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 277
TABLE 339 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 340 ITALY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 341 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 342 ITALY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 278
TABLE 343 ITALY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 278
TABLE 344 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 279
TABLE 345 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 279
TABLE 346 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 279
TABLE 347 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 280
TABLE 348 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 349 SPAIN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 350 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 351 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 282
TABLE 352 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 282
TABLE 353 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 282
TABLE 354 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 283
TABLE 355 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 283
TABLE 356 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 284
TABLE 357 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 358 REST OF EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 359 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 360 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 285
TABLE 361 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 286
TABLE 362 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 286
TABLE 363 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 286
TABLE 364 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 287
TABLE 365 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 289
TABLE 366 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 289
TABLE 367 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 368 ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 369 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 291
TABLE 370 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 291
TABLE 371 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 292
TABLE 372 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 292
TABLE 373 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 292
TABLE 374 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 293
TABLE 375 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 294
TABLE 376 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 294
TABLE 377 CHINA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 294
TABLE 378 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 379 CHINA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 295
TABLE 380 CHINA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 296
TABLE 381 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 296
TABLE 382 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 296
TABLE 383 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 297
TABLE 384 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 298
TABLE 385 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 386 SOUTH KOREA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 387 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 388 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 299
TABLE 389 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 300
TABLE 390 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 300
TABLE 391 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 300
TABLE 392 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 301
TABLE 393 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 302
TABLE 394 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 395 JAPAN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 396 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 397 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 303
TABLE 398 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 304
TABLE 399 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 304
TABLE 400 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 304
TABLE 401 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 305
TABLE 402 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 306
TABLE 403 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 404 INDIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 405 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 406 INDIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 307
TABLE 407 INDIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 307
TABLE 408 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 308
TABLE 409 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 308
TABLE 410 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 308
TABLE 411 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 309
TABLE 412 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 413 AUSTRALIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 414 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 415 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 311
TABLE 416 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 311
TABLE 417 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 311
TABLE 418 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 312
TABLE 419 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 312
TABLE 420 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 313
TABLE 421 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 422 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 423 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 424 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 315
TABLE 425 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 315
TABLE 426 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 315
TABLE 427 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 316
TABLE 428 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 316
TABLE 429 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 317
TABLE 430 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 317
TABLE 431 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 432 LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 433 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 434 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 319
TABLE 435 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 319
TABLE 436 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 319
TABLE 437 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 320
TABLE 438 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 320
TABLE 439 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 321
TABLE 440 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 441 BRAZIL: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 442 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 443 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 322
TABLE 444 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 323
TABLE 445 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 323
TABLE 446 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 323
TABLE 447 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 324
TABLE 448 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 324
TABLE 449 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 450 MEXICO: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 451 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 452 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 326
TABLE 453 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 326
TABLE 454 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 326
TABLE 455 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 327
TABLE 456 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 327
TABLE 457 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 328
TABLE 458 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 459 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 460 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 461 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 329
TABLE 462 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 330
TABLE 463 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 330
TABLE 464 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 330
TABLE 465 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 331
TABLE 466 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION,
2024–2031 (USD MILLION) 331
TABLE 467 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 332
TABLE 468 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 469 MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 470 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 333
TABLE 471 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 333
TABLE 472 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 333
TABLE 473 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 334
TABLE 474 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 334
TABLE 475 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 334
TABLE 476 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 335
TABLE 477 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 335
TABLE 478 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 479 GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 480 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 481 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 337
TABLE 482 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 337
TABLE 483 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 337
TABLE 484 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 338
TABLE 485 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 338
TABLE 486 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 339
TABLE 487 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 488 SAUDI ARABIA: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 489 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 490 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 340
TABLE 491 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 340
TABLE 492 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 341
TABLE 493 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 341
TABLE 494 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 341
TABLE 495 UAE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 342
TABLE 496 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 497 UAE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 343
TABLE 498 UAE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 499 UAE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 343
TABLE 500 UAE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 344
TABLE 501 UAE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 344
TABLE 502 UAE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 344
TABLE 503 UAE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 345
TABLE 504 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 345
TABLE 505 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 506 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 507 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 508 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 347
TABLE 509 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 347
TABLE 510 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 347
TABLE 511 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 348
TABLE 512 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 348
TABLE 513 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 349
TABLE 514 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 515 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 516 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 350
TABLE 517 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY MOLECULE TYPE, 2024–2031 (USD MILLION) 350
TABLE 518 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY CELL TYPE, 2024–2031 (USD MILLION) 351
TABLE 519 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 351
TABLE 520 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY PROCESS MODE, 2024–2031 (USD MILLION) 351
TABLE 521 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET,
BY END USER, 2024–2031 (USD MILLION) 352
TABLE 522 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 352
TABLE 523 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 353
TABLE 524 AFRICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE,
2024–2031 (USD MILLION) 353
TABLE 525 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 353
TABLE 526 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024–2031 (USD MILLION) 354
TABLE 527 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024–2031 (USD MILLION) 354
TABLE 528 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 354
TABLE 529 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE,
2024–2031 (USD MILLION) 355
TABLE 530 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024–2031 (USD MILLION) 355
TABLE 531 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, JANUARY 2023–JULY 2026 356
TABLE 532 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION 360
TABLE 533 SINGLE-USE BIOREACTORS MARKET: REGION FOOTPRINT 364
TABLE 534 SINGLE-USE BIOREACTORS MARKET: PRODUCT FOOTPRINT 365
TABLE 535 SINGLE-USE BIOREACTORS MARKET: TYPE FOOTPRINT 366
TABLE 536 SINGLE-USE BIOREACTORS MARKET: APPLICATION FOOTPRINT 367
TABLE 537 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF
KEY STARTUPS/SMES, 2025 370
TABLE 538 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES, BY PRODUCT AND REGION, 2025 372
TABLE 539 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES,
JANUARY 2023–JULY 2026 375
TABLE 540 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2023–JULY 2026 376
TABLE 541 SINGLE-USE BIOREACTORS MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 377
TABLE 542 SARTORIUS AG: COMPANY OVERVIEW 378
TABLE 543 SARTORIUS AG: PRODUCTS OFFERED 379
TABLE 544 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 381
TABLE 545 SARTORIUS AG: DEALS, JANUARY 2023–JULY 2026 381
TABLE 546 SARTORIUS AG: EXPANSIONS, JANUARY 2023–JULY 2026 382
TABLE 547 DANAHER CORPORATION: COMPANY OVERVIEW 384
TABLE 548 DANAHER CORPORATION: PRODUCTS OFFERED 386
TABLE 549 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 388
TABLE 550 DANAHER CORPORATION: DEALS, JANUARY 2023–JULY 2026 388
TABLE 551 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 389
TABLE 552 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 391
TABLE 553 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 393
TABLE 554 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,
JANUARY 2023–JULY 2026 394
TABLE 555 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JULY 2026 395
TABLE 556 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–JULY 2026 396
TABLE 557 MERCK KGAA: COMPANY OVERVIEW 398
TABLE 558 MERCK KGAA: PRODUCTS OFFERED 400
TABLE 559 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 401
TABLE 560 MERCK KGAA: DEALS, JANUARY 2023–JULY 2026 401
TABLE 561 MERCK KGAA: EXPANSIONS, JANUARY 2023–JULY 2026 402
TABLE 562 AVANTOR, INC.: COMPANY OVERVIEW 404
TABLE 563 AVANTOR, INC.: PRODUCTS OFFERED 406
TABLE 564 AVANTOR, INC.: DEALS, JANUARY 2023–JULY 2026 407
TABLE 565 AVANTOR, INC.: EXPANSIONS, JANUARY 2023–JULY 2026 407
TABLE 566 REPLIGEN CORPORATION: COMPANY OVERVIEW 408
TABLE 567 REPLIGEN CORPORATION: PRODUCTS OFFERED 410
TABLE 568 REPLIGEN CORPORATION: DEALS, JANUARY 2023–JULY 2026 411
TABLE 569 REPLIGEN CORPORATION: EXPANSION, JANUARY 2023–JULY 2026 411
TABLE 570 GETINGE AB: COMPANY OVERVIEW 412
TABLE 571 GETINGE AB: PRODUCTS OFFERED 414
TABLE 572 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 415
TABLE 573 GETINGE AB: DEALS, JANUARY 2023–JULY 2026 415
TABLE 574 GETINGE AB: EXPANSIONS, JANUARY 2023–JULY 2026 416
TABLE 575 EPPENDORF SE: COMPANY OVERVIEW 417
TABLE 576 EPPENDORF SE: PRODUCTS OFFERED 418
TABLE 577 EPPENDORF SE: DEALS, JANUARY 2023–JULY 2026 419
TABLE 578 EPPENDORF SE: EXPANSIONS, JANUARY 2023–JULY 2026 419
TABLE 579 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW 420
TABLE 580 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 422
TABLE 581 ENTEGRIS: COMPANY OVERVIEW 423
TABLE 582 ENTEGRIS: PRODUCTS OFFERED 425
TABLE 583 SAINT-GOBAIN: COMPANY OVERVIEW 426
TABLE 584 SAINT-GOBAIN: PRODUCTS OFFERED 427
TABLE 585 SAINT-GOBAIN: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 428
TABLE 586 SAINT-GOBAIN: EXPANSIONS, JANUARY 2023–JULY 2026 428
TABLE 587 CORNING INCORPORATED: COMPANY OVERVIEW 429
TABLE 588 CORNING INCORPORATED: PRODUCTS OFFERED 430
TABLE 589 LONZA: COMPANY OVERVIEW 431
TABLE 590 LONZA: PRODUCTS OFFERED 432
TABLE 591 LONZA: DEALS, JANUARY 2023–JULY 2026 433
TABLE 592 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: COMPANY OVERVIEW 434
TABLE 593 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCTS OFFERED 434
TABLE 594 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 435
TABLE 595 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: EXPANSIONS,
JANUARY 2023–JULY 2026 435
TABLE 596 ZACROS CORPORATION: COMPANY OVERVIEW 436
TABLE 597 ZACROS CORPORATION: PRODUCTS OFFERED 437
TABLE 598 ADOLF KÜHNER AG: COMPANY OVERVIEW 438
TABLE 599 OMNIBRX BIOTECHNOLOGIES PVT LTD.: COMPANY OVERVIEW 439
TABLE 600 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 440
TABLE 601 PBS BIOTECH, INC.: COMPANY OVERVIEW 441
TABLE 602 BBI-BIOTECH GMBH: COMPANY OVERVIEW 442
TABLE 603 ABEC, INC.: COMPANY OVERVIEW 443
TABLE 604 ESCO LIFESCIENCES GROUP: COMPANY OVERVIEW 444
TABLE 605 DISTEK, INC.: COMPANY OVERVIEW 445
TABLE 606 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW 446
TABLE 607 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW 447
TABLE 608 MICRODIGITAL CO., LTD.: COMPANY OVERVIEW 448
TABLE 609 BIONET: COMPANY OVERVIEW 449
TABLE 610 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 450
TABLE 611 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW 451
TABLE 612 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW 451
TABLE 613 PHARMNXT BIOTECH: COMPANY OVERVIEW 452
TABLE 614 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW 452
TABLE 615 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW 453
TABLE 616 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 463
TABLE 617 RISK ASSESSMENT 466

LIST OF FIGURES

FIGURE 1 SINGLE-USE BIOREACTORS MARKET SEGMENTATION & REGIONS COVERED 43
FIGURE 2 SINGLE-USE BIOREACTORS MARKET: YEARS CONSIDERED 45
FIGURE 3 MARKET SCENARIO 48
FIGURE 4 GLOBAL SINGLE-USE BIOREACTORS MARKET, 2024–2031 48
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2023–2026 49
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF SINGLE-USE BIOREACTORS MARKET 50
FIGURE 7 HIGH-GROWTH SEGMENTS IN SINGLE-USE BIOREACTORS MARKET, 2026–2031 51
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SINGLE-USE BIOREACTORS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 52
FIGURE 9 INCREASING BIOLOGICS, BIOSIMILARS, VACCINES, AND CELL & GENE THERAPY MANUFACTURING EXPANSION TO PROPEL MARKET GROWTH 53
FIGURE 10 US AND SINGLE-USE BIOREACTOR SYSTEMS SEGMENT COMMANDED LARGEST MARKET SHARES IN 2025 54
FIGURE 11 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD 55
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 56
FIGURE 13 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 57
FIGURE 14 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT
FACILITY VS. MULTI-PRODUCT FACILITY 60
FIGURE 15 COMPARISON BETWEEN SINGLE-PRODUCT AND MULTI-PRODUCT FACILITIES 61
FIGURE 16 BIOSIMILAR APPROVALS & LAUNCHES, 2015–2025 63
FIGURE 17 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL
IN US/EU, 2012−2025 63
FIGURE 18 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 72
FIGURE 19 GLOBAL GDP GROWTH, 2020–2030 75
FIGURE 20 SINGLE-USE BIOREACTORS MARKET: VALUE CHAIN ANALYSIS 76
FIGURE 21 SINGLE-USE BIOREACTORS MARKET ECOSYSTEM 78
FIGURE 22 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS,
BY TYPE, 2023–2025 (USD) 82
FIGURE 23 AVERAGE SELLING PRICE OF KEY SINGLE-USE BIOREACTOR PRODUCTS,
BY REGION, 2025 (USD) 84
FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90
FIGURE 25 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTORS PATENTS, 2015–2025 100
FIGURE 26 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET 104
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTOR PRODUCTS 115
FIGURE 28 KEY BUYING CRITERIA, BY END USER 117
FIGURE 29 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 250
FIGURE 30 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 288
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2021–2025 (USD BILLION) 358
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2025 359
FIGURE 33 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 362
FIGURE 34 SINGLE-USE BIOREACTORS MARKET: COMPANY FOOTPRINT 363
FIGURE 35 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 369
FIGURE 36 EV/EBITDA OF KEY VENDORS, 2026 373
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS, 2026 373
FIGURE 38 SINGLE-USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 374
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2025) 379
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 385
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 392
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2025) 399
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT (2025) 405
FIGURE 44 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2025) 409
FIGURE 45 GETINGE AB: COMPANY SNAPSHOT (2025) 413
FIGURE 46 EPPENDORF SE: COMPANY SNAPSHOT (2025) 417
FIGURE 47 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2025) 421
FIGURE 48 ENTEGRIS: COMPANY SNAPSHOT (2025) 424
FIGURE 49 SAINT-GOBAIN: COMPANY SNAPSHOT (2025) 426
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 429
FIGURE 51 LONZA: COMPANY SNAPSHOT (2025) 432
FIGURE 52 ZACROS CORPORATION: COMPANY SNAPSHOT (2025) 436
FIGURE 53 SINGLE-USE BIOREACTORS MARKET: RESEARCH DESIGN 454
FIGURE 54 SINGLE-USE BIOREACTORS MARKET: BREAKDOWN OF PRIMARIES 456
FIGURE 55 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025 457
FIGURE 56 SINGLE-USE BIOREACTORS MARKET: COMPANY REVENUE
ANALYSIS (BOTTOM-UP APPROACH) (2025) 458
FIGURE 57 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE ANALYSIS (2025) 458
FIGURE 58 SINGLE-USE BIOREACTORS MARKET: INSIGHTS FROM PRIMARIES 459
FIGURE 59 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 460
FIGURE 60 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS 462
FIGURE 61 SINGLE-USE BIOREACTORS MARKET: DATA TRIANGULATION 464

---

---